Authors:
HAUBRICH R
LALEZARI J
FOLLANSBEE SE
GILL MJ
HIRSCH M
RICHMAN D
MILDVAN D
BURGER HU
BEATTIE D
DONATACCI L
SALGO MP
Citation: R. Haubrich et al., IMPROVED SURVIVAL AND REDUCED CLINICAL PROGRESSION IN HIV-INFECTED PATIENTS WITH ADVANCED DISEASE TREATED WITH SAQUINAVIR PLUS ZALCITABINE, Antiviral therapy, 3(1), 1998, pp. 33-42
Citation: J. Lalezari, SELECTING THE OPTIMUM DOSE FOR A NEW SOFT GELATIN CAPSULE FORMULATIONOF SAQUINAVIR, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 195-197
Authors:
BOYER D
CANTRILL H
JAFFE G
KUPPERMANN B
LALEZARI J
LAMBERT M
LIEBERMAN R
PARK S
TERRY B
Citation: D. Boyer et al., RELATIVE RISK ASSESSMENT OF RETINAL-DETACHMENT OR ENDOPHTHALMITIS WITH INTRAVITREAL INJECTIONS OF EYES WITH CMV RETINITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3412-3412
Authors:
DEEKS SG
COLLIER A
LALEZARI J
PAVIA A
RODRIGUE D
DREW WL
TOOLE J
JAFFE HS
MULATO AS
LAMY PD
LI WX
CHERRINGTON JM
HELLMANN N
KAHN J
Citation: Sg. Deeks et al., THE SAFETY AND EFFICACY OF ADEFOVIR DIPIVOXIL, A NOVEL ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) THERAPY, IN HIV-INFECTED ADULTS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(6), 1997, pp. 1517-1523
Authors:
LALEZARI J
SCHACKER T
FEINBERG J
GATHE J
LEE S
CHEUNG T
KRAMER F
KESSLER H
COREY L
DREW WL
BOGGS J
MCGUIRE B
JAFFE HS
SAFRIN S
Citation: J. Lalezari et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CIDOFOVIR GELFOR THE TREATMENT OF ACYCLOVIR-UNRESPONSIVE MUCOCUTANEOUS HERPES-SIMPLEX VIRUS-INFECTION IN PATIENTS WITH AIDS, The Journal of infectious diseases, 176(4), 1997, pp. 892-898
Authors:
COHEN OJ
PANTALEO G
HOLODNIY M
FOX CH
ORENSTEIN JM
SCHNITTMAN S
NIU M
GRAZIOSI C
PAVLAKIS GN
LALEZARI J
BARTLETT JA
STEIGBIGEL RT
COHN J
NOVAK R
MCMAHON D
BILELLO J
FAUCI AS
Citation: Oj. Cohen et al., ANTIRETROVIRAL MONOTHERAPY IN EARLY-STAGE HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE HAS NO DETECTABLE EFFECT ON VIRUS LOAD IN PERIPHERAL-BLOOD AND LYMPH-NODES, The Journal of infectious diseases, 173(4), 1996, pp. 849-856
Authors:
DREW WL
ANDERSON R
LANG W
MINER RC
DAVIS G
LALEZARI J
Citation: Wl. Drew et al., FAILURE OF HIGH-DOSE ORAL ACYCLOVIR TO SUPPRESS CMV VIRURIA OR INDUCEGANCICLOVIR-RESISTANT CMV IN HIV ANTIBODY-POSITIVE PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 289-291
Authors:
SYLVESTER A
CALIENDO A
AN D
SAVARA A
BYINGTON R
STRICK D
LILLANEY R
SUTTON L
SEPKOWITZ K
FISCHL M
SIMON G
LALEZARI J
MITSUYASU R
DAQUILA R
Citation: A. Sylvester et al., HIV-1 RESISTANCE MUTATIONS AND PLASMA RNA DURING ZIDOVUDINE PLUS ZALCITABINE COMBINATION THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 47-47
Authors:
COHEN OJ
PANTALEO G
HOLODNIY M
SCHNITMAN S
NIU M
GRAZIOSI C
PAVLAKIS GN
LALEZARI J
BARTLETT JA
STEIGBIGEL RT
COHN J
NOVAK R
MCMAHON D
FAUCI AS
Citation: Oj. Cohen et al., DECREASED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PLASMA VIREMIA DURING ANTIRETROVIRAL THERAPY REFLECTS DOWN-REGULATION OF VIRAL REPLICATION INLYMPHOID-TISSUE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(13), 1995, pp. 6017-6021